Literature DB >> 33497555

Distribution of KRAS G12C Somatic Mutations across Race, Sex, and Cancer Type.

Amin H Nassar1, Elio Adib1, David J Kwiatkowski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33497555     DOI： 10.1056/NEJMc2030638

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

Review 1.  Synthetic Vulnerabilities in the KRAS Pathway.

Authors:  Marta Roman; Elizabeth Hwang; E Alejandro Sweet-Cordero
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

2.  FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.

Authors:  Erica C Nakajima; Nicole Drezner; Xiaoxue Li; Pallavi S Mishra-Kalyani; Yajun Liu; Hong Zhao; Youwei Bi; Jiang Liu; Atiqur Rahman; Emily Wearne; Idara Ojofeitimi; Lauren Tesh Hotaki; Dianne Spillman; Richard Pazdur; Julia A Beaver; Harpreet Singh
Journal:  Clin Cancer Res       Date:  2022-04-14       Impact factor: 13.801

3.  Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.

Authors:  Rodrigo Cavagna; Flávia Escremim de Paula; Débora Sant'Anna; Iara Santana; Vinicius D da Silva; Eduardo C A da Silva; Carlos E Bacchi; José E Miziara; Josiane M Dias; Pedro De Marchi; Leticia F Leal; Rui M Reis
Journal:  JCO Glob Oncol       Date:  2021-04

4.  Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer.

Authors:  Li Zhou; Litang Huang; Qiuli Xu; Yanling Lv; Zimu Wang; Ping Zhan; Hedong Han; Yang Shao; Dang Lin; Tangfeng Lv; Yong Song
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

5.  A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors.

Authors:  Siyu Feng; Marinella G Callow; Jean-Philippe Fortin; Zia Khan; David Bray; Mike Costa; Zhen Shi; Weiru Wang; Marie Evangelista
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-26       Impact factor: 12.779

6.  Calling Attention to the Role of Race-Driven Societal Determinants of Health on Aggressive Tumor Biology: A Focus on Black Americans.

Authors:  Kimlin T Ashing; Veronica Jones; Fornati Bedell; Tanyanika Phillips; Loretta Erhunmwunsee
Journal:  JCO Oncol Pract       Date:  2021-07-13

7.  The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.

Authors:  Keigo Chida; Daisuke Kotani; Toshiki Masuishi; Takeshi Kawakami; Yasuyuki Kawamoto; Kyoko Kato; Kunihiro Fushiki; Kentaro Sawada; Ryosuke Kumanishi; Hiromichi Shirasu; Yuki Matsubara; Satoshi Yuki; Yoshito Komatsu; Kentaro Yamazaki; Takayuki Yoshino
Journal:  Oncologist       Date:  2021-07-07

8.  Acquired Resistance to KRASG12C Inhibition in Cancer.

Authors:  Mark M Awad; Shengwu Liu; Igor I Rybkin; Kathryn C Arbour; Julien Dilly; Viola W Zhu; Melissa L Johnson; Rebecca S Heist; Tejas Patil; Gregory J Riely; Joseph O Jacobson; Xiaoping Yang; Nicole S Persky; David E Root; Kristen E Lowder; Hanrong Feng; Shannon S Zhang; Kevin M Haigis; Yin P Hung; Lynette M Sholl; Brian M Wolpin; Julie Wiese; Jason Christiansen; Jessica Lee; Alexa B Schrock; Lee P Lim; Kavita Garg; Mark Li; Lars D Engstrom; Laura Waters; J David Lawson; Peter Olson; Piro Lito; Sai-Hong I Ou; James G Christensen; Pasi A Jänne; Andrew J Aguirre
Journal:  N Engl J Med       Date:  2021-06-24       Impact factor: 91.245

Review 9.  Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer.

Authors:  Ryan M Carr; Zhaohui Jin; Joleen Hubbard
Journal:  Cancers (Basel)       Date:  2021-05-01       Impact factor: 6.639

Review 10.  Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification.

Authors:  Natsuki Osaka; Yoshihisa Hirota; Doshun Ito; Yoshiki Ikeda; Ryo Kamata; Yuki Fujii; Venkat R Chirasani; Sharon L Campbell; Koh Takeuchi; Toshiya Senda; Atsuo T Sasaki
Journal:  Front Mol Biosci       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.